Author:
Balan Vijayan,Rosati Marianne J.,Anderson Machiko H.,Rakela Jorge
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference14 articles.
1. Manns MP, McHutchison JG, Gordon SC, et al.: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958–965, 2001
2. Fried MW, Shiffman ML, Reddy KR, et al.: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975–982, 2002
3. Blatt LM, Davis JM, Klein SB, et al.: The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon. J Interferon Cytokine Res 16:489–499, 1996
4. Fauci AS, Rosenberg SA, Sherwin SA, et al.: Immunomodulators in clinical medicine. Ann Intern Med 106:421–433, 1987
5. Wang T, Ozes O, Tan H, et al.: The combination of type 1 (IFN Alfacon-1) and type 2 (IFN Gamma-1b) interferons enhances Th1 and natural killer cell responses: implications for resolution of chronic HCV infection in difficult-to-treat patients. Gastroenterology 128:S925, 2005
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献